{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:17:39Z","timestamp":1778660259047,"version":"3.51.4"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1093\/jac\/44.6.787","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:40:19Z","timestamp":1027723219000},"page":"787-790","source":"Crossref","is-referenced-by-count":18,"title":["Antifungal activity of amphotericin B\u2013lipid admixtures in experimental systemic candidosis in naive mice"],"prefix":"10.1093","volume":"44","author":[{"given":"Yona","family":"Shadkchan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Segal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,12]]},"reference":[{"key":"key\n\t\t\t\t20170411034843_R1","doi-asserted-by":"crossref","unstructured":"Shadkhan, Y., Segal, E., Bor, A., Gov, Y., Rubin, M. & Lichtenberg, D. (1997). The use of commercially available lipid emulsions for the preparation of amphotericin B\u2013lipid admixtures. Journal of Antimicrobial Chemotherapy39, 655\u20138.","DOI":"10.1093\/jac\/39.5.655"},{"key":"key\n\t\t\t\t20170411034843_R2","doi-asserted-by":"crossref","unstructured":"Gallis, H. A. (1996). Amphotericin B: a commentary on its role as an antifungal agent and as a comparative agent in clinical trials. Clinical Infectious Diseases22, Suppl. 2, s145\u20137.","DOI":"10.1093\/clinids\/22.Supplement_2.S145"},{"key":"key\n\t\t\t\t20170411034843_R3","unstructured":"Graybill, J. R., Revankar, S. G. & Patterson, T. F. (1998). Systemic antifungal drugs in current use. In Microbiology and Microbial Infections. 9th edn, (Topley & Wilson, Eds), pp. 163\u20135. Arnold, Great Britain."},{"key":"key\n\t\t\t\t20170411034843_R4","doi-asserted-by":"crossref","unstructured":"Brajtburg, J. & Bolard, J. (1996). Carrier effects on biological activity of amphotericin B. Clinical Microbiology Reviews9, 512\u201331.","DOI":"10.1128\/CMR.9.4.512"},{"key":"key\n\t\t\t\t20170411034843_R5","doi-asserted-by":"crossref","unstructured":"Sabra, R. & Branch, R. A. (1990). Amphotericin B nephrotoxicity. Drug Safety5, 94\u2013108.","DOI":"10.2165\/00002018-199005020-00003"},{"key":"key\n\t\t\t\t20170411034843_R6","doi-asserted-by":"crossref","unstructured":"Gates, C. & Pinney, R. J. (1993). Amphotericin B and its delivery by liposomal and lipid formulations. Journal of Clinical Pharmacy and Therapeutics8, 147\u201353.","DOI":"10.1111\/j.1365-2710.1993.tb00605.x"},{"key":"key\n\t\t\t\t20170411034843_R7","doi-asserted-by":"crossref","unstructured":"Brajtburg, J., Powderly, W. G., Kobayashi, G. S. & Medoff, G. (1990). Amphotericin B: Delivery systems. Antimicrobial Agents and Chemotherapy34, 381\u20134.","DOI":"10.1128\/AAC.34.3.381"},{"key":"key\n\t\t\t\t20170411034843_R8","unstructured":"Janoff, A. S. (1990). Liposomes and lipid structures as carriers of amphotericin B. Journal of Clinical Microbiology and Infectious Diseases9, 146\u201351."},{"key":"key\n\t\t\t\t20170411034843_R9","doi-asserted-by":"crossref","unstructured":"Hiemenz, J. W. & Walsh, T. J. (1996). Lipid formulations of Amphotericin B: recent progress and future directions. Clinical Infectious Diseases22, Suppl. 2, s133\u201344.","DOI":"10.1093\/clinids\/22.Supplement_2.S133"},{"key":"key\n\t\t\t\t20170411034843_R10","doi-asserted-by":"crossref","unstructured":"Levy, R., Segal, E. & Eylan, E. (1981). Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions.Infection and Immunity31, 874\u20138.","DOI":"10.1128\/IAI.31.3.874-878.1981"},{"key":"key\n\t\t\t\t20170411034843_R11","doi-asserted-by":"crossref","unstructured":"Levy, M. Y., Polachek, I., Barenholz, Y. & Benita, S. (1993). Efficacy evaluation of a novel submicron Amphotericin B emulsion in murine candidiasis. Journal of Medical and Veterinary Mycology31, 207\u201318.","DOI":"10.1080\/02681219380000261"},{"key":"key\n\t\t\t\t20170411034843_R12","doi-asserted-by":"crossref","unstructured":"Ryley, J. F. (1990). Screening and evaluation in vivo. In Handbook of Experimental Pharmacology: Chemotherapy of Fungal Diseases. Vol 96, (Ryley, J. F., Ed.) pp. 129\u201336. Springer-Verlag, Germany.","DOI":"10.1007\/978-3-642-75458-6_6"},{"key":"key\n\t\t\t\t20170411034843_R13","unstructured":"Anaissiae, E.J., Pinczowski, H. & Louria, D. B. (1993). Candida infections in experimental animals. In Candidiasis: Pa6thogenesis, Diagnosis and Treatment. 2nd edn, (Bodey, Ed.), pp. 43\u201357. Raven Press, New York."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/44\/6\/787\/13057176\/JAC446787.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T08:52:42Z","timestamp":1583311962000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/44.6.787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":13,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,12]]},"published-print":{"date-parts":[[1999,12]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/44.6.787","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}